Tag:

Loramyc

Latest Headlines

Latest Headlines

SpePharm demands $46.4M from BioAlliance Pharma

Amsterdam-based SpePharm Holding has filed a €35 million claim against BioAlliance Pharma for the "brutal termination" of a licensing agreement for the commercialization of the antifungal drug